This study of medical records in a prospectively maintained database identifies factors associated with survival in patients with periampullary adenocarcinomas and compares survival between those having intestinal-type or pancreaticobiliary-type cancers originating from the duodenum, ampulla, or distal common bile duct with those having pancreatic ductal adenocarcinoma.
This decision analytic study models different techniques for reducing the cost of complex surgery performed at safety-net hospitals.
This observational study examines the databases of 3 institutions to compare the incidence of wound infections after pancreaticoduodenectomy as well as the microorganisms identified on cultures and the effectiveness of institution-based perioperative antibiotic protocols.
This study of patients undergoing hepatopancreaticobiliary surgery reports significant variability in hospital costs associated with patient and hospital characteristics.
This retrospective review of perioperative outcome parameters supports the safe implementation of robotic pancreaticoduodenectomy. See also the Invited Commentary by Edil.
This retrospective analysis of a prospectively collected institutional database linked to statewide data of patients who underwent pancreatectomy at a tertiary care referral center finds that 21.5% of patients required early readmission after pancreatectomy.
Brown and coauthors evaluate the effect of hospital length of stay and postoperative complications on total charges in patients undergoing elective pancreaticoduodenectomy.
Zhou et al compare patients who underwent retrograde pancreaticoduodenectomy with 15 of those operated on through a conventional approach.
Gall et al examine the impact of 2 different surgical techniques, standard pancreaticoduodenectomy and no-touch isolation pancreaticoduodenectomy, on tumor behavior and outcome in patients with pancreatic cancer by using circulating tumor cells as biomarkers.
Kadera and colleagues aimed to perform a detailed survival analysis of their institution’s experience with patients with locally advanced/borderline resectable pancreatic ductal adenocarcinoma who were downstaged and underwent surgical resection and (2) identify prognostic biomarkers that may help guide a decision for the use of adjuvant therapy in this patient subgroup. L. Andrew DiFronzo, MD, provided an invited commentary.
Zenoni and coauthors provide a retrospective review of all published studies in the English literature in which a minimally invasive pancreaticoduodenectomy was performed. The purpose of this article is to review the available literature regarding early postoperative outcomes and the technical challenges of minimally invasive pancreaticoduodenectomy, including robotic techniques.
Hyder and colleagues conducted a retrospective cohort study to evaluate patient-, surgeon-, and hospital-level factors associated with readmission. Mark Bloomston, MD, provided a related invited commentary.